Victoria's Secret & Co (VSXY) Stock Price Today
Oculis completes patient randomization in trial for precision treatment of TNFR1-mediated dry eye disease
Oculis Holding AG has completed patient randomization in its PREDICT-1 clinical trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). Two-thirds of the 176 enrolled patients carry a genetic variant linked to...
Ekalia partners with Telix to boost astatine-211 production in the US for cancer therapy.
Ekalia, a joint venture between IBA and Framatome, has signed a collaboration agreement with Telix Pharmaceuticals to accelerate the production of astatine-211 in the United States. Astatine-211 is a promising alpha-emitting radioisotope used in targ...
Roche unveils pivotal cancer drug data at ESMO 2026, highlighting advances in lung and breast cancer treatments.
At ESMO 2026, Roche presented key Phase III trial results showcasing significant advances in cancer treatment. Divarasib demonstrated superior efficacy over first-generation KRAS G12C inhibitors in advanced lung cancer, potentially setting a new stan...
GSK's lung cancer drug shows 61% response rate in early global trial at higher dose
GSK announced that its experimental lung cancer drug, risvutatug rezetecan, achieved a 61% confirmed response rate at the higher 8 mg/kg dose in an early global trial involving patients with relapsed extensive-stage small cell lung cancer. This respo...
Senior loans and Franklin Senior Loan ETF benefit from wider credit spreads and Fed rate hikes.
Senior loans are expected to perform well due to wider credit spreads and recent Federal Reserve interest rate hikes. The Franklin Senior Loan ETF (FLBL) stands out as a strong option in this category, offering a growing dividend yield of 7.6%. This ...
Oil supply risks grow as US eases Russia sanctions amid attacks on Gulf and Russian oil infrastructure.
The US has temporarily eased sanctions on Russian crude oil, suspending duties that could have reached 100% on major buyers, potentially increasing supply. However, oil supply risks have widened due to attacks on tankers and oil infrastructure in the...
Oculis completes patient randomization in trial for precision medicine Licaminlimab targeting dry eye disease.
Oculis Holding AG has completed patient randomization in its PREDICT-1 trial testing Licaminlimab, a precision medicine targeting TNFR1-mediated dry eye disease (DED). The trial enrolled 176 patients, two-thirds carrying a genetic variant linked to b...
Capitan Silver discovers deep, high-grade silver and polymetallic mineralization at Cruz de Plata in Mexico.
Capitan Silver Corp. announced new assay results from 22 drill holes at its Cruz de Plata project in Durango, Mexico, revealing a new discovery of Carbonate Replacement Deposit (CRD) mineralization 500 meters below the Jesus Maria Silver Trend. The r...
PetroTal appoints Emily Morris as Head of Investor Relations, enhancing global investor engagement.
PetroTal Corp. has appointed Emily Morris as its new Head of Investor Relations, based in London. Morris, who has been on PetroTal's Board since 2023 and advised the company since 2018, will focus on expanding engagement with the global investment co...
EchoStar gains Speculative Buy rating on $20B SpaceX spectrum sale and debt restructuring plans
EchoStar Corporation received a Speculative Buy rating due to its $20 billion spectrum sale agreement with SpaceX and ongoing efforts to restructure its debt. Despite challenges like declining revenue, subscriber losses, and weaker margins compared t...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.